Our Customers
Products & Pipeline
Science & DTx
For business
Solutions
Clinicians
Investors
About us
Contact us
FacebookTwitterLinkedinYouTube
NHS
US Payers
next arrow
Back
Company news
All
2 Min Read

Dr Andy Blackwell speaks to pharmaphorum about ieso’s latest study conducted with support from Roche Diabetes Ltd

02 Aug 2022
By
ieso

ieso’s Group Chief Science and Strategy Officer, Dr Andy Blackwell recently featured in pharmaphorum's article “Beyond the pill in an outcome-based world”.

It examines how pharmaceutical-led patient support programmes can be supplemented and supported by additional healthcare interventions, particularly mental health support. Andy explained to her how our recent study, conducted with support from Roche Diabetes Care Limited, found that tailored, online cognitive behavioural therapy (CBT) can not only improve mental health outcomes for diabetes patients, but can also boost quality of life, reduce diabetes distress, and, crucially, improve self-management of their condition.

Read the full article here. If you’d like to read more about our further scientific research, click here.

About pharmaphorum:

pharmaphorum combines industry-leading publications, strategic consulting and a content-driven stakeholder engagement agency. pharmaphorum.com, and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate.

ieso
ieso’s Group Chief Science and Strategy Officer, Dr Andy Blackwell features in pharmaphorum's article “Beyond the pill in an outcome-based world”

Read more

For our latest Team Spotlight interview, we spoke to Brendon Kelly who recently joined ieso as Head of US Business Development.
Company news
5 min read
19th March 2025

In this team spotlight interview, we spoke to Brendon Kelly about his role as Head of US Business Development.

Acceptability of a Conversational Agent-led Digital Program for Anxiety: A Mixed-Methods Study of Patient Perspectives
Research papers
2025

Researchers conducted a study to understand if patients who used the ieso Digital Program for anxiety found it acceptable, engaging, and usable.

ieso Digital Health Appoints Kent Tangen as New CEO to Drive Digital Mental Health Innovation in the United States
Company news
6 Min Read
1st November 2024

ieso Digital Health, a leader in digital mental healthcare, names Kent Tangen as CEO to lead US expansion. With 25+ years in healthcare, finance, retail, media, and more, Kent joins ieso's mission to deliver accessible, high-quality digital mental healthcare to all who need it.